v3.26.3
Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Preferred stock
Series A Preferred Stock
Preferred stock
Series A Preferred Stock
Conversion of Series A Preferred Stock to Common Stock
Preferred stock
Series B Preferred Stock
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Preferred stock, beginning balance (in shares) at Dec. 31, 2024       120,790.402   437,927        
Beginning balance at Dec. 31, 2024 $ (6,802)     $ 0   $ 0 $ 3 $ 689,887 $ (692,071) $ (4,621)
Common stock, beginning balance (in shares) at Dec. 31, 2024             25,767,369      
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of options (in shares)             55,690      
Issuance of common stock upon exercise of options 183             183    
Issuance of common stock upon vesting of restricted stock units (in shares)             113,042      
Stock-based compensation expense 2,508             2,508    
Currency translation adjustment 32                 32
Net loss (17,710)               (17,710)  
Preferred stock, ending balance (in shares) at Mar. 31, 2025       120,790.402   437,927        
Ending balance at Mar. 31, 2025 (21,789)     $ 0   $ 0 $ 3 692,578 (709,781) (4,589)
Common stock, ending balance (in shares) at Mar. 31, 2025             25,936,101      
Preferred stock, beginning balance (in shares) at Dec. 31, 2024       120,790.402   437,927        
Beginning balance at Dec. 31, 2024 (6,802)     $ 0   $ 0 $ 3 689,887 (692,071) (4,621)
Common stock, beginning balance (in shares) at Dec. 31, 2024             25,767,369      
Increase (Decrease) in Stockholders' Equity                    
Currency translation adjustment 34                  
Net loss (37,726)                  
Preferred stock, ending balance (in shares) at Sep. 30, 2025       120,790.402   437,927        
Ending balance at Sep. 30, 2025 (35,844)     $ 0   $ 0 $ 3 698,537 (729,797) (4,587)
Common stock, ending balance (in shares) at Sep. 30, 2025             26,003,606      
Preferred stock, beginning balance (in shares) at Mar. 31, 2025       120,790.402   437,927        
Beginning balance at Mar. 31, 2025 (21,789)     $ 0   $ 0 $ 3 692,578 (709,781) (4,589)
Common stock, beginning balance (in shares) at Mar. 31, 2025             25,936,101      
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of options (in shares)             25,690      
Issuance of common stock upon exercise of options 85             85    
Issuance of common stock upon vesting of restricted stock units (in shares)             38,274      
Stock-based compensation expense 3,279             3,279    
Currency translation adjustment 12                 12
Net loss 15,886               15,886  
Preferred stock, ending balance (in shares) at Jun. 30, 2025       120,790.402   437,927        
Ending balance at Jun. 30, 2025 (2,527)     $ 0   $ 0 $ 3 695,942 (693,895) (4,577)
Common stock, ending balance (in shares) at Jun. 30, 2025             26,000,065      
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of options (in shares)             1,564      
Issuance of common stock upon exercise of options 5             5    
Issuance of common stock upon vesting of restricted stock units (in shares)             1,977      
Stock-based compensation expense 2,590             2,590    
Currency translation adjustment (10)                 (10)
Net loss (35,902)               (35,902)  
Preferred stock, ending balance (in shares) at Sep. 30, 2025       120,790.402   437,927        
Ending balance at Sep. 30, 2025 $ (35,844)     $ 0   $ 0 $ 3 698,537 (729,797) (4,587)
Common stock, ending balance (in shares) at Sep. 30, 2025             26,003,606      
Preferred stock, beginning balance (in shares) at Dec. 31, 2025 0 120,790.402 437,927 120,790.402   437,927        
Beginning balance at Dec. 31, 2025 $ (126,240)     $ 0   $ 0 $ 3 700,706 (822,373) (4,576)
Common stock, beginning balance (in shares) at Dec. 31, 2025 26,011,106           26,011,106      
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of options (in shares)             93,632      
Issuance of common stock upon exercise of options $ 304             304    
Issuance of common stock upon vesting of restricted stock units (in shares)             169,278      
Issuance of common stock through at the market offering, net of commissions and expenses (in shares)             2,270,712      
Issuance of common stock through at the market offering, net of commissions and expenses 14,584             14,584    
Stock-based compensation expense 2,423             2,423    
Currency translation adjustment (7)                 (7)
Net loss (39,182)               (39,182)  
Preferred stock, ending balance (in shares) at Mar. 31, 2026       120,790.402   437,927        
Ending balance at Mar. 31, 2026 $ (148,118)     $ 0   $ 0 $ 3 718,017 (861,555) (4,583)
Common stock, ending balance (in shares) at Mar. 31, 2026             28,544,728      
Preferred stock, beginning balance (in shares) at Dec. 31, 2025 0 120,790.402 437,927 120,790.402   437,927        
Beginning balance at Dec. 31, 2025 $ (126,240)     $ 0   $ 0 $ 3 700,706 (822,373) (4,576)
Common stock, beginning balance (in shares) at Dec. 31, 2025 26,011,106           26,011,106      
Increase (Decrease) in Stockholders' Equity                    
Currency translation adjustment $ (45)                  
Net loss $ (34,885)                  
Preferred stock, ending balance (in shares) at Sep. 30, 2026 0 98,050.372 437,927 98,050.372   437,927        
Ending balance at Sep. 30, 2026 $ (130,467)     $ 0   $ 0 $ 3 731,409 (857,258) (4,621)
Common stock, ending balance (in shares) at Sep. 30, 2026 30,487,384           30,487,384      
Preferred stock, beginning balance (in shares) at Mar. 31, 2026       120,790.402   437,927        
Beginning balance at Mar. 31, 2026 $ (148,118)     $ 0   $ 0 $ 3 718,017 (861,555) (4,583)
Common stock, beginning balance (in shares) at Mar. 31, 2026             28,544,728      
Increase (Decrease) in Stockholders' Equity                    
Conversion of Series A Preferred Stock to common stock (in shares)         (22,740.03)   758,001      
Issuance of common stock upon exercise of options (in shares)             192,209      
Issuance of common stock upon exercise of options 373             373    
Issuance of common stock through at the market offering, net of commissions and expenses (in shares)             543,024      
Issuance of common stock through at the market offering, net of commissions and expenses 4,692             4,692    
Stock-based compensation expense 2,083             2,083    
Currency translation adjustment (25)                 (25)
Net loss 15,769               15,769  
Preferred stock, ending balance (in shares) at Jun. 30, 2026       98,050.372   437,927        
Ending balance at Jun. 30, 2026 (125,226)     $ 0   $ 0 $ 3 725,165 (845,786) (4,608)
Common stock, ending balance (in shares) at Jun. 30, 2026             30,037,962      
Increase (Decrease) in Stockholders' Equity                    
Issuance of common stock upon exercise of options (in shares)             64,977      
Issuance of common stock upon exercise of options 112             112    
Issuance of common stock upon vesting of restricted stock units (in shares)             1,978      
Issuance of common stock through at the market offering, net of commissions and expenses (in shares)             382,467      
Issuance of common stock through at the market offering, net of commissions and expenses 3,471             3,471    
Stock-based compensation expense 2,661             2,661    
Currency translation adjustment (13)                 (13)
Net loss $ (11,472)               (11,472)  
Preferred stock, ending balance (in shares) at Sep. 30, 2026 0 98,050.372 437,927 98,050.372   437,927        
Ending balance at Sep. 30, 2026 $ (130,467)     $ 0   $ 0 $ 3 $ 731,409 $ (857,258) $ (4,621)
Common stock, ending balance (in shares) at Sep. 30, 2026 30,487,384           30,487,384